Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2025-12-24 @ 1:40 PM
NCT ID:
NCT00811395
Eligibility Criteria:
Inclusion Criteria:
* PDY6045 or PDY6046 participant who:
* completed the week 24 visit of either study PDY6045 or PDY6046,
* was still meeting eligibility criteria for receiving treatment,
* had agreed to continue stable dose of Interferon-β \[IFN-β\] or Glatiramer Acetate \[GA\] and consented to continue on treatment.
Exclusion Criteria:
* Any known condition or circumstance that would have prevented in the investigator's opinion, compliance or completion of the study
The above information is not intended to contain all considerations relevant to patient's potential participation in a clinical trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00811395
Study Brief:
Protocol Section:
NCT00811395